Depression as a microglial disease.
By R. Yirmiya, N. Rimmerman, R. Reshef. Trends in Neurosciences, 2015
812 citations recorded by the source corpus.
Subfields: Behavioral Neuroscience, Biological Psychiatry, Neurology
View Paper: https://www.semanticscholar.org/paper/a0ac19e196ebb13de48d176d93745bb674f7bd56
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Behavioral Neuroscience
- C. Nemeroff
- Eléonore Beurel
- M. Toups
- S. Mazmanian
- T. Sampson
- Charles L Raison
- Andrew H. Miller
- Michael Joseph Meaney
In Biological Psychiatry
- C. Nemeroff
- Eléonore Beurel
- M. Toups
- T. Sampson
- S. Mazmanian
- Charles L Raison
- Andrew H. Miller
- J. Cryan
In Neurology
Citations in the corpus
- Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies (2017, background): “Evidence pointing to a role of M1 cells (including microglial cells and CNS macrophages) in MDD has accumulated (2, 65).”
- The Central Nervous System and the Gut Microbiome (2016, background): “One hypothesis claims that depression, or subsets of this disorder, is a microglial disorder, as the onset of depression often follows intense inflammatory episodes in the brain or, conversely, decline in microglial function (Yirmiya et al., 2015).”
- The Bidirectional Relationship of Depression and Inflammation: Double Trouble (2020, background): “, synapse pruning and neurogenesis) and are activated in many neurodegenerative and neuropsychiatric diseases, where they contribute to pathology by promoting neuroinflammation (Yirmiya et al., 2015).”